Navigation Links
VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial

esults to differ materially from current expectations include, but are not limited to:

-- our ability to obtain necessary financing;

-- our ability to control our operating expenses;

-- our ability to recruit and enroll patients for the ACS and FDG-PET

clinical trials;

-- failure to obtain sufficient data from enrolled patients that can be

used to evaluate VIA-2291, thereby impairing the validity or

statistical significance of our clinical trials;

-- our ability to successfully complete our clinical trials of VIA-2291

on expected timetables and the outcomes of such clinical trials;

-- complexities in designing and implementing cardiovascular clinical

trials using histological examinations, measurement of biomarkers,

medical imaging and atherosclerotic plaque bioassays;

-- the results of our clinical trials, including without limitation, with

respect to the safety and efficacy of VIA-2291;

-- the outcome of any legal proceedings;

-- our ability to obtain necessary FDA approvals;

-- our ability to successfully commercialize VIA-2291;

-- our ability to obtain and protect our intellectual property related to

our product candidates;

-- our potential for future growth and the development of our product


-- our ability to form and maintain collaborative relationships to

develop and commercialize our product candidates;

-- general economic and business conditions; and

-- the other risks described under Item IA "Risk Factors" in our Annual

Report on Form 10-K for the fiscal year ended December 31, 2007 on

file with the SEC.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain ... a leading retail drugstore chain in China ... stores, today announced the resignation of Mr. Fuxiang ... personal reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... the Company,s board of directors, effective immediately. Meanwhile, Ms. ...
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "North American ... Digit Replacement, Elbow Replacement, Hip Replacement, Knee ... report to their offering. ,     (Logo: ... was valued at $4,470.9 million in 2014 ...
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... CLEVELAND, Feb. 10, 2011 Medicare beneficiaries are reporting ... following the January 1, 2011 implementation of Medicare,s "competitive" ... many of the more than 640,000 seniors and people ... enrolled in Medicare. The bidding program began ...
... 2011 USANA Health Sciences, Inc. (NYSE: ... gaps are common in the average American diet and that ... gaps.  However, USANA scientists and advising physicians caution that many ... Dietary Guidelines for Americans, 2010 and that ...
Cached Medicine Technology:Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 2Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 3USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2
(Date:5/22/2015)... (PRWEB) May 22, 2015 In an ... Parker and Sons is offering to donate $5 dollars ... an AC unit or water softening system. Customers have ... Parker and Sons gets business; and the Special Olympics ... The Special Olympics helps over 4.4 million athletes, and ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President and ... by Consulting-Specifying Engineer (CSE) magazine as a young leader ... the May/June issue of the publication. , This award ... and younger who have, and continue to make significant ... other areas of their professional and personal endeavors. Candidates ...
(Date:5/22/2015)... 22, 2015 In April 2006, Veatch ... past 9 years they have concentrated their focus to ... and Canada. Because of this growth and their goals ... offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas and ... opening new dental offices, dental start ups, orthodontic practices, ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Co founders Greenlee ... is to allow general dentists to immediately deliver fully integrated ... based on that of the medical surgeon. , The ... main roadblocks preventing general dentists from placing dental implants. ... necessary steps to introduce the surgical placement of dental implants ...
(Date:5/22/2015)... A new program for the "In America" television ... Physical Therapy. , James Earl Jones will host ... physical therapy and discusses how the exercises can decrease ... of ailments and injuries. Physical therapists work with ... enhances daily activities such as house cleaning and shopping, ...
Breaking Medicine News(10 mins):Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2
... 2010Announcing the launch of the Liebert Mobile iPhone ... news, resources, press releases, research, and multimedia content ... across the biomedical, biotechnology, medicine, surgery, and nursing, ... available with this free application. Updated ...
... Addicts ... ... economic times like these many students are postponing or quitting their educational pursuits for financial ... addict these challenges are not only real but exacerbated due to their personal fight. Today, ...
... while 87% of younger patients got it after surgery , ... are less likely than younger ones to receive potentially life-prolonging ... , The research indicates that those with advanced colon cancer ... likely to receive chemotherapy and more likely to receive less ...
... in the signature bracelet -- that they give to supporters when they make a minimum $15.00 donation -- they immediately took action.  The ... ... , ... ...
... to be associated with more appropriate follow-up and shorter ... an abnormal result on a mammogram, according to a ... of Internal Medicine , one of the JAMA/Archives journals. ... for Research on Inner City Health, St. Michael,s Hospital, ...
... News media, scientists and others interested in finance, entrepreneurship ... American Chemical Society (ACS) Small & Medium Business Webinar ... with subject matter experts and global thought leaders in ... of interest to scientific and engineering professionals. Each ...
Cached Medicine News:Health News:Academy's Community Initiative Offers Qualifying Former Addicts Free Vocational Training 2Health News:Older Colon Cancer Patients Less Likely to Get Chemo 2Health News:Older Colon Cancer Patients Less Likely to Get Chemo 3Health News:Older Colon Cancer Patients Less Likely to Get Chemo 4Health News:An Update on Mel's Bracelet 2
... FastPach is an accurate, reliable, portable, ... screenings. It works off of a ... of the device a breeze. The ... make operating and viewing results simple. ...
The Cordis ANGIOGUARD® Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures....
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
Medicine Products: